Advocate Advocacy Tools

Have a Heart, Save My Liver! Where is the Cure Registered?

Eight years since the approval of the breakthrough treatment, sofosbuvir, which effectively cures hepatitis C, new direct-acting antivirals (DAAs) regimens have been approved and a variety of treatment access strategies have been used to increase countries’ access.

The hepCoalition developed a fact sheet, based on crowdsourced hepatitis C data from mapCrowd, a free, public database managed by Treatment Action Group and Médecins du Monde. The fact sheet provides in-country data from 82 countries to further understand where the branded and generic versions of the cure have been registered and to inform advocacy efforts for generating demand that could speed up registration. The fact sheet provides supplemental evidence, using community and in-country data, to further understand the registration gaps for direct-acting antivirals (DAAs). The data highlights the availability and registration of DAAs for community leaders and policy makers to reflect in their national elimination advocacy work.